AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  ACS Chemical Neuroscience

• Publication date

  2013-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/cn400132uPMID 23898966PMCID PMC3778431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen receptor‐β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model

  2013cited by this paper
• Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis

  2013cited by this paper
• Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Estrogen synthesis and signaling pathways during aging: from periphery to brain.

  2013cited by this paper
• Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons

  2012cited by this paper
• Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship

  2012cited by this paper
• Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

  2012cited by this paper
• Nrf2-Keap1 Antioxidant Defense and Cell Survival Signaling Are Upregulated by 17β-Estradiol in Homocysteine-Treated Dopaminergic SH-SY5Y Cells

  2012cited by this paper
• Habitual intake of dietary flavonoids and risk of Parkinson disease

  2012cited by this paper
• Proteolytic degradation of amyloid β-protein.

  2012cited by this paper
• The assessment of non-feminizing estrogens for use in neuroprotection.

  2011cited by this paper
• Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

  2011cited by this paper
• Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease

  2011cited by this paper
• The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.

  2011cited by this paper
• Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive Impairment

  2010cited by this paper
• Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines

  2010cited by this paper
• Efficacy and safety of a selective estrogen receptor β agonist, ERB‐041, in patients with rheumatoid arthritis: A 12‐week, randomized, placebo‐controlled, phase II study

  2010cited by this paper
• Mitochondrial mechanisms of estrogen neuroprotection.

  2010cited by this paper
• Estrogen Receptor β Is a Novel Therapeutic Target for Photoaging

  2010cited by this paper
• Estrogen Stimulates Degradation of β-Amyloid Peptide by Up-regulating Neprilysin*

  2009cited by this paper
• Protective actions of sex steroid hormones in Alzheimer's disease.

  2009cited by this paper
• Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist.

  2008cited by this paper
• Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory

  2008cited by this paper
• Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.

  2008cited by this paper
• Androgens regulate neprilysin expression: role in reducing β‐amyloid levels

  2008cited by this paper
• Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment.

  2007cited by this paper
• Estrogen suppresses brain mitochondrial oxidative stress in female and male rats.

  2007cited by this paper
• Hormonal therapy with patch or pill: How much does it matter?

  2007cited by this paper
• Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout.

  2006cited by this paper
• An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.

  2002cited by this paper
• Measurement of Startle Response, Prepulse Inhibition, and Habituation

  1998cited by this paper

• Sexual Dimorphism in Levodopa‐Induced Dyskinesia Following Parkinson's Disease: Uncharted Territory

  2025cites this paper
• The selective ERβ agonist AC 186 reduces polyinosinic:polycytidylic acid (poly I:C)-induced inflammatory responses in BEAS-2B lung epithelial cells

  2025cites this paper
• 3A. Estrogen receptors in GtoPdb v.2025.3

  2025cites this paper
• Motor and Non-Motor Effects of Acute MPTP in Adult Zebrafish: Insights into Parkinson’s Disease

  2025cites this paper
• Analogues of the Potent and Selective ERβ Agonist trans -4-(4-Hydroxyphenyl)cyclohexanemethanol: Synthesis and Evaluation

  2024cites this paper
• Inhibition of neuroinflammation and neuronal damage by the selective non-steroidal ERβ agonist AC-186

  2024influential citation
• Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases

  2024cites this paper
• Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression.

  2023cites this paper
• The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.

  2023cites this paper
• The X factor in neurodegeneration

  2022cites this paper
• Parkinson's disease in Women: Mechanisms underlying sex differences.

  2021cites this paper
• 3A. Estrogen receptors in GtoPdb v.2021.3

  2021cites this paper
• 25 years of ERβ: a personal journey.

  2021cites this paper
• Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation.

  2021cites this paper
• Cytisine is neuroprotective in female but not male 6‐hydroxydopamine lesioned parkinsonian mice and acts in combination with 17‐β‐estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons

  2020cites this paper
• A synthesis strategy for tetracyclic terpenoids leads to agonists of ERβ

  2019cites this paper
• Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders

  2019cites this paper
• Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. Analysis of sex differences.

  2019cites this paper
• Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders

  2019cites this paper
• Synthesis and Discovery of Estra-1,3,5(10),6,8-pentaene-2,16α-diol.

  2018cites this paper
• Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics.

  2017cites this paper
• Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

  2017influential citation
• Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis

  2017cites this paper
• Synthesis of gem-difluorocyclopentane/hexane building blocks

  2017cites this paper
• Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain.

  2016cites this paper
• Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

  2016cites this paper
• Consequences of Estrogen Receptor Beta Phosphorylation in the Aged Female Brain and Heart

  2016cites this paper
• bedside research : Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis

  2016influential citation
• Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update

  2015cites this paper
• [Progress in study of selective ERβ ligands].

  2015cites this paper
• Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease.

  2015cites this paper
• Composés et compositions utilisés pour traiter les maladies neurodégénératives

  2014cites this paper
• Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

  2014cites this paper
• Impact of estrogen receptor beta activation on functional recovery after experimental stroke.

  2014cites this paper
• Sex differences in Parkinson's disease and other movement disorders.

  2014cites this paper
• The A-CD analogue of 16 beta,17 alpha-estriol is a potent and highly selective estrogen receptor beta agonist

  2013cites this paper
• Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

  2013cites this paper
• Iranian Journal of Basic Medical Sciences Estrogen Agonist Genistein Differentially Influences the Cognitive and Motor Disorders in an Ovariectomized Animal Model of Parkinsonism Introduction

  year unknowncites this paper